ZCMD
Zhongchao Inc.
$1.74
+0.09 (+5.45%)
At close · Jul 16
Market Cap
$2.01M
Shares
1,156,544
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$11.37M
-28.3%
FY2025
Net Income
-$6.31M
-881%
FY2025
Gross Margin
45.02%
-11.2pp
FY2025
Operating Margin
-54.43%
-52.3pp
FY2025
Diluted EPS
-$172.05
-86.9%
FY2025
Operating Cash Flow
$845.39K
+157.4%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| $11.37M | $15.86M | $19.43M | $14.15M | $16.3M | $17.99M | $14.88M | |
| $343.13K | $243.01K | $237.05K | $142.01K | $175.99K | $146.97K | — | |
| $6.25M | $6.95M | $10.92M | $7.79M | $6.86M | $6.12M | $4.66M | |
| $5.12M | $8.91M | $8.51M | $6.36M | $9.44M | $11.87M | $10.23M | |
| 45.02% | 56.18% | 43.8% | 44.92% | 57.92% | 65.99% | 68.72% | |
| $8085 | $252.45K | $514.41K | $411.52K | $758.88K | $816.55K | $864.32K | |
| $1.49M | $4.01M | $6.71M | $2.1M | $3.14M | $3.44M | $3.2M | |
| $9.81M | $4.99M | $6.7M | $6.8M | $5.86M | $3.12M | $2.52M | |
| $4958 | $4953 | $335.54K | $119.22K | $5525 | $4544 | $6234 | |
| $290.18K | $231.11K | $518.49K | — | — | — | — | |
| $11.31M | $9.25M | $21.8M | $9.31M | $9.76M | $7.38M | $6.58M | |
| -$6.19M | -$341.27K | -$13.28M | -$2.95M | -$320.74K | — | — | |
| -54.43% | -2.15% | -68.35% | -20.88% | -1.97% | — | — | |
| -$5.9M | -$110.16K | -$12.77M | — | — | — | — | |
| $79.41K | $160.02K | $1.07M | $262.44K | $34K | $305.57K | $534.02K | |
| — | -$24.5K | -$229 | — | -$13.76K | -$25.62K | — | |
| -$5.77M | $61.76K | -$11.98M | -$2.55M | -$110.75K | $4.94M | $4.39M | |
| $46.18K | $335.17K | -$669.76K | $272.31K | -$349.42K | $484.79K | $387.14K | |
| -$6.31M | -$643.23K | -$11.34M | -$2.82M | $238.67K | $4.46M | $4.05M | |
| -55.47% | -4.05% | -58.33% | -19.94% | 1.46% | 24.78% | 27.19% | |
| $495.29K | $369.82K | $28.67K | $118.57K | -$1283 | -$1283 | $46.17K | |
| — | — | — | -$2.94M | $238.67K | — | — | |
| -$5.91M | -$1.12M | -$12.06M | -$4.65M | $520.46K | $5.72M | $3.83M | |
| USD/shares | -$172.05 | -$92.07 | -$3,239.19 | -$840.72 | $74.40 | — | — |
| USD/shares | -$172.05 | -$92.07 | -$3,239.19 | -$840.72 | — | — | — |
| shares | 36.76K | 6996.5376 | 3499.129 | 3494.3222 | — | 3283.0157 | 2903.244 |
| shares | 36.76K | 6996.5376 | 3499.129 | 3494.3222 | 3351.9507 | 3283.0157 | 2903.244 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| MDMOOC Services | $10,678,554 | $13,712,964 | $10,406,734 | $12,935,420 |
| Sales of Patented Drugs | $696,442 | $2,151,809 | $9,027,211 | $1,216,096 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Medical Training and Education Services | $6,858,034 | $7,704,812 | $6,385,735 | $6,604,487 | $8,754,120 |
| Patient Management Services in Patient Aid Projects | $3,820,520 | $6,008,152 | $4,020,999 | $6,288,602 | $7,343,343 |
| Sales of Patented Drugs | $696,442 | $2,151,809 | $9,027,211 | $1,216,096 | — |
| Product | — | $2,151,809 | $9,027,211 | $1,216,096 | — |
| Service | — | $13,712,964 | $10,406,734 | $12,935,420 | — |
| Other Revenues | — | $97,782 | $22,544 | $42,331 | $199,307 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Sales of Patented Drugs | $42,241 | $323,841 | $1,658,040 | $430,362 |
| MDMOOC Services | -$6,233,466 | -$665,108 | -$14,941,838 | -$3,384,824 |
Operating Margin by Segment (%)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| MDMOOC Services | -58.4% | -4.9% | -143.6% | -26.2% |
| Sales of Patented Drugs | 6.1% | 15% | 18.4% | 35.4% |
Key facts
CIK
1785566
CUSIP
G9897X149